Literature DB >> 835595

Systemic lupus erythematosus within the first two decades of life.

A J Fish, E B Blau, N G Westberg, B A Burke, R L Vernier, A F Michael.   

Abstract

Forty-nine patients with systemic lupus erythematosus (SLE) during childhood and adolescence presenting over a period of 17 years were followed during treatment with prednisone and azathioprine. The average period of follow-up was 5.7 years. Detailed analyses of clinical parameters of renal function and sequential changes in glomerular abnormalities by percutaneous renal biopsy are reported. Therapy was directed towards normalizing the results of urinalysis and renal function, eliminating proteinuria and maintaining normal serology (normal serum complement and negative antiDNA titers). The 10 year survival of the entire group was 86 per cent. A survival of 73 per cent and 87 per cent over this interval in patients with diffuse and focal proliferative lupus nephritis, respectively, was achieved. The major cause of mortality in this series was infection. It appears that intensive observation and monitoring of serologic parameters in SLE, along with aggressive steroid and immunosuppressive therapy, lead to a prognosis in SLE more favorable than previously reported.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835595     DOI: 10.1016/0002-9343(77)90355-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Multifocal ischemic necrosis of bone in scleroderma.

Authors:  V Fossaluzza; A Peressini; S De Vita
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

2.  Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.

Authors:  Cristina Arriens; Sixia Chen; David R Karp; Ramesh Saxena; Kamalanathan Sambandam; Eliza Chakravarty; Judith A James; Joan T Merrill
Journal:  Clin Immunol       Date:  2016-12-03       Impact factor: 3.969

3.  End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Authors:  Linda T Hiraki; Bing Lu; Steven R Alexander; Tamara Shaykevich; Graciela S Alarcón; Daniel H Solomon; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2011-07

Review 4.  The influence of sex hormones on the disease systemic lupus erythematosus.

Authors:  R G Lahita
Journal:  Springer Semin Immunopathol       Date:  1986

Review 5.  Advances in the care of children with lupus nephritis.

Authors:  Scott E Wenderfer; Natasha M Ruth; Hermine I Brunner
Journal:  Pediatr Res       Date:  2016-11-17       Impact factor: 3.756

Review 6.  Systemic lupus erythematosus in children.

Authors:  A M Rosenberg
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Systemic lupus erythematosus in childhood.

Authors:  F Caeiro; F M Michielson; R Bernstein; G R Hughes; B M Ansell
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

8.  Childhood systemic lupus erythematosus in songklanagarind hospital: a potential unique subgroup.

Authors:  P Vachvanichsanong; P Dissaneewate
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

9.  Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders.

Authors:  J D Hardy; S Solomon; G S Banwell; R Beach; V Wright; F M Howard
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

Review 10.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.